Consistent evidence of activity of ecteinascidin (ET-743) in pretreated, advanced soft tissue sarcoma (ASTS): results from a pooled analysis of three pivotal phase II clinical trials (p2ct) and safety profile of a 24 h infusion schedule

✍ Scribed by A. Le Cesne; J.L. Misset; G. Demetri; J.A. Lopez-Martin; J.Y. Blay; A. van Oosterom; I. Judson; E. Brain; A. Yovine; R. Maki; J. Gomez; C. Guzman

• Book ID: 117657976
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 172 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)80606-7